IP Library Granted Patent US 10,646,598
Granted Patent B2
US 10,646,598 · App. 15/194,425 · Granted May 12, 2020

Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same

Inventors: Peter S. Conti (Pasadena, CA); Hancheng Cai (Alhambra, CA); Zibo Li (Logan, UT); Shuanglong Liu (Alhambra, CA)
Assignee: University of Southern California
A61K51/0474A61K51/0482A61K51/082A61K51/088A61K51/1093C07D487/04C07D487/08C07K5/1021C07K7/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,646,598
App. No.
15/194,425
Granted
May 12, 2020
Kind
B2
Abstract

Disclosed is a class of versatile Sarcophagine based bifunctional chelators (BFCs) containing a hexa-aza cage for labeling with metals having either imaging, therapeutic or contrast applications radiolabeling and one or more linkers (A) and (B). The compounds have the general formula where A is a functional group selected from group consisting of an amine, a carboxylic acid, an ester, a carbonyl, a thiol, an azide and an alkene, and B is a functional group selected from the group consisting of hydrogen, an amine, a carboxylic acid, and ester, a carbonyl, a thiol, an azide and an alkene. Also disclosed are conjugate of the BFC and a targeting moiety, which may be a peptide or antibody. Also disclosed are metal complexes of the BFC/targeting moiety conjugates that are useful as radiopharmaceuticals, imaging agents or contrast agents.

Claims (9)

1. A chemical composition comprising a molecule selected from the group consisting of

wherein the molecule is complexed with a metal or metal ion.

2. The chemical composition according to claim 1 , wherein the metal is selected from the group consisting of 90 Y, Gd, 68 Ga, 57 Co, 60 Co, 52 Fe, 64 Cu and 67 Cu.

3. A bifunctional chelator and targeting moiety conjugate comprising a molecule selected from the group consisting of

wherein the targeting moiety is selected from the group consisting of a peptide and an antibody.

4. The bifunctional chelator and targeting moiety conjugate according to claim 3 , wherein the peptide is selected from the group consisting of a RGD, Asp-Gly-Glu-Ala (DGEA), bombesin peptides (BBN), and uPAR peptides.

5. A method of positron emission tomography (PET) imaging comprising:

introducing into a subject a chemical composition according to claim 2 ; and

imaging the subject after introducing the composition.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 24, 2023
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 062490/0998 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2016
From: CONTI, PETER S.; CAI, HANCHENG; LI, ZIBO; LIU, SHUANGLONG
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 040638/0356 →
Continuity (3)
Division 12695125 · Jan 27, 2010
Provisional Application 61147709 · Jan 27, 2009
Related Publication 20170189567A1 · Jul 6, 2017